Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 3/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5076849 | 1.00 | ALDH1A1 (0.44) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL2140558 | 0.91 | ALDH1A1 (0.43) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL2138421 | 0.90 | ALDH1A1 (0.42) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL13897067 | 0.85 | ALDH1A1 (0.53) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL14213298 | 0.85 | ALDH1A1 (0.53) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL10388301 | 0.85 | ALDH1A1 (0.53) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL2138385 | 0.85 | ALDH1A1 (0.43) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL2136203 | 0.84 | ALDH1A1 (0.42) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL12568208 | 0.83 | ALDH1A1 (0.46) | ALDH1A1HPGDPOLBKMT2ARAB9A | |
| SCHEMBL948162 | 0.83 | ALDH1A1 (0.49) | ALDH1A1HPGDPOLBKMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1937734-B1 | BIOCIDAL POLYMERS | KE KELIT KUNSTSTOFFWERK GES M B H (AT) | 2018-04-04 | — | — | EP | disclosed |
| US-8148484-B2 | Poly(bicyclo[2.2.1]hept-5-ene-2-carboxylic acid 2-(tert-butylamino)ethyl ester); Poly(bicyclo[2.2.1]hept-5-ene-2-carboxylic acid 2-(dimethylamino)ethyl ester); used for disinfecting, sterilizing, and preventing biofouling in closed or open industrial-water systems and cooling-water systems | KE KELIT KUNSTSTOFFWERK GESMBH (AT) | 2012-04-03 | — | — | US | disclosed |
| US-20090221684-A1 | Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof | TRUSTEES OF BOSTON UNIVERSITY (US) | 2009-09-03 | — | — | US | disclosed |
| US-20090221684-A1 | Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof | TRUSTEES OF BOSTON UNIVERSITY (US) | 2009-09-03 | — | — | US | disclosed |
| US-20080251460-A1 | Biocidal Polymers | KE KELIT KUNSTSTOFFWERK GESMBH (AT) | 2008-10-16 | — | — | US | disclosed |
| EP-1937734-A2 | BIOCIDAL POLYMERS | KE-KELIT Kunststoffwerk Gesellschaft m.b.H. (AT) | 2008-07-02 | — | — | EP | disclosed |
| WO-2007073489-A2 | MOLECULES FOR GENE DELIVERY AND GENE THERAPY, AND METHODS OF USE THEREOF | TRUSTEES OF BOSTON UNIVERSITY (US) | 2007-06-28 | — | — | WO | disclosed |
| WO-2007045634-A2 | BIOCIDAL POLYMERS | KE KELIT KUNSTSTOFFWERK GESMBH (AT) | 2007-04-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221684-A1 | Molecules for Gene Delivery and Gene Therapy, and Methods of Use Thereof | ANXA6, STING1, ADM2 | ALDH1A1 2863/4885HPGD 3738/4885POLB 761/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.